- Perioperative glucose: The CMS measure 2028 budgets have underpriced
- OIG flags Pennsylvania behavioral insurer for faulty prior auth denials
- Independence Health to open 28-bed behavioral health unit
- ICON Dental Partners appoints VP of dental partnerships
- University Hospitals vice president of strategy and partnerships retires
- Heartland Dental adds Missouri practice
- US healthcare affordability hits 5-year low: Gallup
- 4 dentists making headlines
- Growing ketamine use raises safety concerns
- AI’s growing role in mental healthcare: 5 notes
- FDA panel backs 1st mRNA flu vaccine
- Does ASC consolidation have a ceiling?
- CVS to join Medicare GLP-1 program, lower costs
- FDA seeks testosterone therapy label changes
- Beyond the dashboard: Why the most damaging denials never get flagged
- Washington lawmakers eye corporate medicine ban after Oregon’s PeaceHealth test
- AbbVie expands immunology pipeline with $10.9B acquisition
- Feds push for more intel on No Surprises Act
- 180 hospital and health system CFOs to know | 2026
- Pennsylvania cardiology group opens new $8.2M ASC
- UM Health-Sparrow breaks ground on $60M ASC
- Colonoscopy remains the gold standard for colorectal cancer screening, AGA says
- Clover Hill Dairy Recalls All Cheese in Deadly Listeria Outbreak
- Nurse practitioner sentenced for $12M Medicare fraud
- Middle-Aged Women Drink More, Know Less About Breast Cancer Risk
- Ensemble Health Partners secures strategic growth investment from Thoreau
- CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences
- CARsgen makes history as China approves world's first CAR-T therapy for solid tumors
- High Hurdles Thwart Kidney Patients' Pursuit Of Life-Saving Transplants
- Rising Healthcare Costs Leave Many Americans Less Secure
- Short Videos Help First-Time Dads Learn Newborn Safety Basics
- Federal Push To Increase U.S. Primary Care Docs Has Fizzled, Study Says
- US to investigate Germany's proposed drug spending reforms
- Alnylam scolded over promotional activity after Pfizer complaint
- They're Uninsured After Obamacare Became Too Costly. And They're Far From Alone.
- Indiana Takes On Powerful Hospitals by Capping Prices They Charge Employers
- Prosper AI lands $30M backed by Andreessen Horowitz to build AI workforce for healthcare operations
- Eli Lilly, Novo Nordisk top AI citation share as new report questions DTC spend culture
- Fish Oil Supplements May Be A Bust For Alzheimer's Prevention
- Prehab Can Boost Seniors' Recuperation From Spinal Fusion Surgery, Trial Finds
- Dog Owners Feel Similar Grief Whether Pets Euthanized, Die Naturally
- Ozempic Might Cut Risk Of Broken Bones, Study Says
- Massage Guns Can Cause Eye Damage, Vision Loss, Case Report Warns
- A 5-month sprint: Behind Pfizer’s $10B deal and Innovent’s global pharma ambition
- 1st free dental clinic opens in New Jersey
- 5 dental insurance changes dentists need to know from the past 15 days
- Indiana dental office manager sentenced to 36 months in prison for Medicaid fraud
- 5 cardiology leaders building the ASC ownership model
- What it actually takes to launch cardiac ablations in an ASC
- 5 federal, state legislative updates affecting the dental workforce
- How many dentists the largest DSOs support
- 8 new behavioral health projects to know
- Anesthesia has a usage problem not a workforce shortage, leaders say
- Remain or Reimagine: Free Interactive Tool Shows Dentists the value of remaining independent vs partnering with Elevate
- Pennsylvania dental group settles patient coverage lawsuit for $1M
- Pennsylvania physicians push back on consolidation with first-ever independent practice summit
- Oregon prosecutors urge state to fix mental health system
- The case for layering behavioral healthcare models
- Rural, independent Kansas hospitals launch clinically integrated network
- 12 behavioral health services, facility closures | 2026
- Higher, short-acting opioid doses linked to 8% lower discharge risk: 4 notes
- 14,700 bottles of antidepressant recalled over impurity concerns
- FTC orders Aurobindo to divest 4 drugs to complete $250M Lannett acquisition
- Congressional Budget Office calls for more research on No Surprises Act unintended impacts
- HHS opens applications for $700M in mental health, addiction funding, with $96M for new STREETS program
- Ebola Infections Climb, Could Take Year To Contain, Health Officials Say
- Why a deviation investigation still takes two weeks in the age of AI
- Feeling Sleepy During the Day? It Could Be a Warning Sign for High Blood Pressure
- FTC, states sue transgender health association over 'misleading' gender care guidance
- Healthcare organizations still struggle to operationalize AI at scale: Arcadia survey
- Pfizer hunts for new CFO as Denton prepares to hang up gloves, wave goodbye to pharma
- Major League Pitchers Might Avoid Elbow Injuries By Altering Their Approach, Simulation Suggests
- Birth Control Pills Might Increase Binge Eating Risk, Study Finds
- Women Might Lower Their Heart Risk By Lifting Weights, Study Says
- Personalized Brain Implant Provides Step-By-Step Walking Boost For Parkinson's Patients
- Amid industry’s cell therapy automation push, Cellares and Ori dominate the field: report
- Most Americans Are Surviving Cancer. But The Mental Health Challenges Can Persist.
- Listen to the Latest ‘KFF Health News Minute’
- Readers Curse Medical Debt and Defend Spelling Therapy
- Arrests of Immigrant Parents Create Mental Health Crisis for Children
- Sandwiched Between Caring for Kids and Aging Parents? Reach Out for Resources
- Novo's success with oral Wegovy has been fueled by 'familiarity': Spherix
- Preparing for LEAD: Why post-acute visibility is the key to long-term value-based success
- One Medical Seniors reports data breach of third-party vendor impacting 'limited' number of patients
- A look at Epic's long-term play to build tech for operations, starting with scheduling
- U.K. Moves To Ban Social Media For Children
- Pregnant Woman Exposed to 45 Common Chemicals, Study Finds
- OhioHealth reaches settlement with DOJ, Ohio AG on antitrust lawsuit
- 4 years after snub, GSK partnership helps Spero get Utebzi across FDA finish line
- Despite 'decent' data, Verastem rethinks options for approved oncology combo in pancreatic cancer
- OIG report raises red flags about maternal health 'ghost networks' in Medicaid managed care
- Why It’s Time to Sunset AI Point Solutions and Consolidate Platforms
- Lantern, Marathon Health team up to launch integrated care management model
- The New Frontier of Care Management: Bridging the Empathy Gap with Intelligence
- Novo Nordisk opens Czech plant and unveils $29M upgrade to China facility
- Whoop, HealthEx partner to connect members’ medical records and biometric data
- GSK runs first DTC ad for would-be asthma blockbuster Exdensur
- Novo security breach claimed by hacking groups seeking multi-million-dollar ransoms: reports
- After FDA sign-off, Colorado's drug import plan faces tough road ahead
- Lower Risk Of Death, Clots Among Autoimmune Patients Taking GLP-1 Drugs
- Surgical Menopause Tied To Worse Sexual And Urinary Symptoms
- Post-Op Delirium Common In Seniors, But Not All Hospitals Screen For It
- Nortiva purrs into action with long-acting Lynx platform salvaged from Langer startup
- Why one life insurer is going big on health incentives
- Weekly Rundown: Lumeris adds symptom-checking tool to AI platform; DeepIntent rolls out agentic AI tool for healthcare marketers
- Before you build or buy care navigation AI, answer this
- Early-Onset Cancers Are On The Rise. Knowing Your Family History Is Crucial.
- Minimally Invasive Procedure Eases Arthritis Knee Pain, Study Finds
- More Americans Are Surviving Cancer. But the Mental Health Challenges Can Persist.
- Tennessee Pharmacies Sell Potent Ivermectin, Led by Anti-Vaccine Doctor Who’s Taken ‘Bucketloads’
- Democrats Seek To Spotlight Rising Health Costs by Forcing Vote on Trump Regulation
- Health services deal value holds steady in 2026 with higher bar for investment: PwC
- Big Pharma’s Big Brand: Inside Eli Lilly’s marketing culture
- CMS tightens oversight of accreditation organizations, limits fee-based consulting
- MedPAC offers a look at enrollment hiccups for Medicare beneficiaries
- CDC, FDA Tackle New World Screwworm, Including Drug Authorization
- 'Biopharma ecosystem is back to full health,' fueled by M&A: PwC
- Lifestyle Changes Can Reduce Your Risk For Multiple Chronic Diseases
- FDA, UK drug regulator deepen transatlantic ties with new liaison program
- People Walk, Exercise Less After Starting Ozempic, Zepbound
- Family Finances Shape Children’s Brain Development, Study Finds
- At-Home Blood Pressure Monitoring Reduces Risk of Heart Attack, Stroke
- Moderna hires Novartis vet to lead commercial, upsizes role for Hoge as potential launches loom
- Long-Awaited Rule Aims To Boost ACA Choices While Embracing Higher Deductibles
- Many Men Are Prescribed Testosterone Without Proper Testing
- Backed by Threat of Clawbacks, Feds Wield Tight Grip on $50B Rural Health Fund
- Early-Onset Cancers Are on the Rise. Knowing Your Family History Is Crucial.
- Recipharm channels ‘multi-million-dollar' US manufacturing upgrade, targeting domestic biologics demand
- Organic Baby Formula Recalled Following Botulism Cases
- FDA Approves First Over-the-Counter Glucose Monitor for Children, The Stelo Glucose Biosensor System
- You've Won The Game
- Many Patients Stop And Restart GLP-1 Meds, Study Finds
- Half Of U.S. Parents Track Their Adult Children’s Location
- Taking GLP-1s While On BP Meds May Up Your Risk Of Dizzy Spells, Fainting
- Trust In CDC Plummets Under Trump Administration, New Poll Shows
- Remarks to the US-CEE Connection: Transatlantic Challenges in Law, Business & Policy
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
- Disorder Protection Rule: Statement on the Proposed Amendments to Rule 611 and Other Provisions of Regulation NMS
- Statement on the Proposed Amendments to Regulation NMS
- Beyond China and Japan: How biopharma is expanding rare disease access across Asia-Pacific
- This Old House: Improving and Remodeling Our Registered Offering and Filer Status Regimes
- Peirce Out: Remarks at the U.S. Chamber of Commerce Capital Markets Summit
- Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals
- Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses
- Boston Scientific Plans Indiana Distribution Center, 300 New Jobs
- “Harmonization: We’ll Have Lots to Talk About”
- Remarks at the Investor Advisory Committee Meeting
- A Quarter for Your Thoughts: Remarks at the Meeting of the SEC Investor Advisory Committee
- Remarks at the Investor Advisory Committee Meeting
Michigan healthcare freedom community forum
"Should Texas be allowed to administer “gender-affirming care” to minors? That’s the question at the heart of Senate Bill 14 / House Bill 1686, which seeks to ban it. Proponents of the controversial practice argue that “legislatures shouldn’t be practicing medicine.” But recent testimony from pro-affirming medical professionals before the Texas legislature suggests the need for just such oversight. Delivering false or misleading testimony about minor surgery, mental health, and the evidence backing gender medicine, opponents of the ban inadvertently proved that it is justified.
Start with the question of whether “gender-affirming” surgeries are performed on minors. Last week, physician Cody Miller Pyke assured Texas state senators that “children under the age of eighteen in this country do not have gender reassignment surgery. There isn’t a single case. . . . The rhetoric of mutilating children with scalpels is just fictitious.” Louis Apel, president of the local chapter of the American Academy of Pediatrics, and Jessica Zwiener, a Houston-based endocrinologist, testified that “surgeries are not part of the standard of care for minors.” Zwiener also insisted that “[n]o one is touching these kids’ genitals. There’s not surgery done on minors.”
These physicians are wrong...."
https://www.city-journal.org/article/making-the-case-for-the-other-side
According to Heritage Action, the number of states proposing such bills is now at 40/+.
Heartlander put out this detailed and well-sourced report back in March. Hot links do not copy well, but are available in the original article.
This coming week the Missouri Senate will again see floor debate on Senate Bill 49, legislation designed to protect children from dangerous cross-sex hormones and experimental surgeries.
Especially following the alarming whistleblower reports coming out of the Washington University Transgender Center at St. Louis Children’s Hospital, this common-sense legislation should be an easy win for Missouri families and lawmakers. Senate Democrats, however, continue to block the bill’s path forward.
While left-wing radicals continue to mischaracterize this legislation, it is first important to understand what this law would do, if enacted.
Titled the “Missouri Save Adolescents from Experimentation (SAFE) Act,” this bill would prohibit physicians or other health care providers from providing “sex transition” procedures to minors. The legislation also provides safeguards for medically verifiable disorders of sex development that require medical attention, an important distinction in this highly-charged political debate.
Children, barely of school age, are being subjected to a questionable diagnosis of gender dysphoria that promotes surgeries and prescriptions for cross-sex hormones that are dangerous, life-altering and permanent. This fad-driven form of medical treatment on children is cruel and oftentimes leads to a lifetime of misery, pain and untreated mental illness.
It is wrong to assume everyone advocating for these surgeries and treatments is “doing it for the children.” In fact, providing pharmaceuticals and surgery for children suffering from gender confusion or dysphoria has become a very profitable industry. The surgeries and cross-sex hormone drugs run into the hundreds of thousands of dollars.
This is designer science, scientifically and clinically unproven, and it is being used to target confused parents and vulnerable children for political purposes and for profit. What is certain, however, is that these children will suffer from lifelong medical dependencies that enrich pharmaceutical and medical service providers with little to show in terms of patient benefit.
In reality, after a so-called “sex reassignment” surgery, girls and boys are nearly 20 times more likely to die from suicide than the general population. Up to 98% of children who struggle with their sex as a boy or a girl come to accept their biological sex by adulthood.
The long-term effects of puberty blockers and cross-sex hormones have not been extensively studied. But it’s already clear they can lead to infertility and other irreversible harmful effects that must be dealt with as children mature.
The Missouri Senate is right to focus on protecting children’s health and safety, especially given the recent revelations of negligence, malfeasance, and coercion that have occurred at the Washington University Transgender Center at St. Louis Children’s Hospital. These so-called “transition services” that amputate or severely alter healthy body parts cause irreversible damage that impacts children for the rest of their lives.
Society does not allow minors to get tattoos, purchase cigarettes or vote in elections – we recognize that minors are not ready to make life-altering decisions. Why should children or coerced parents be permitted to allow these cross-sex hormones and surgeries unquestioningly?
Our children deserve quality care and protection from junk science. Body dysphoria, depression anxiety and the awkwardness of puberty are all real challenges that deserve compassion. But, we should not allow our children to be pushed into experimental surgeries and drugs by radical activist groups and rapacious corporations.
This is not a fringe or controversial position for Missouri legislators or citizens to take. All across the United States, state legislatures and governors are now taking a stand to prevent this horrific abuse of minors. Laws similar to Missouri’s SAFE Act have already passed in Alabama, Arkansas, Mississippi, South Dakota, Tennessee, Texas and Utah, with other states such as Georgia and Indiana sure to follow.
Currently, at least 21 states are considering legislation.
Nationwide, parents are demanding the protection of their children from the predatory behaviors of radical school counselors and agenda-driven medical personnel. Missouri policy leaders must join this fight.
The Senate must allow the “Show Me” state to take the lead, and ensure that S.B. 49 sees whatever floor debate is required and pass it on for consideration by the House. Missouri’s kids deserve nothing less.
And now South Carolina, and a roundup of the issue from the Heritage Foundation.
SC Is Protecting Its Children With “Help Not Harm” Bill. More States Should Follow
Mar 14, 2024 3 min read COMMENTARY BY Sarah Parshall Perry, Senior Legal Fellow, Meese CenterAfter passing a Senate subcommittee just days ago, the bill now heads to the full Senate Medical Affairs Committee for a vote. Lawmakers there must show the courage of their colleagues in the House because the bill is precisely the kind of legislation that America’s children need—and need immediately.
In increasing measure, vulnerable pubescent and pre-pubescent children are being proselytized into a fictional belief that they can be “born in the wrong body.” In fact, so effective have been the influences of social media, peer pressure and pro-trans narratives in this space that UCLA School of Law’s Williams Institute reports that more than 300,000 high school-aged (ages 13-17) children in the United States today identify as “transgender”—making them the largest and fastest-growing share of the overall trans-identified population in the country.
Between 2017 and 2021, the number of children in the United States taking puberty blockers or cross-sex hormones doubled. And double mastectomies performed on adolescent girls increased by nearly 400% during the same period.
These increases aren’t organic. They are a direct result of what appears to be a national social experiment targeting children who are not old enough to vote, get tattoos, buy cigarettes or enter into contracts. The federal government has been working overtime to convince the nation that these experimental procedures are “life-saving care” and that if children don’t have access to these “gender affirming” treatments, they will commit suicide.
But the support for such inflammatory rhetoric simply doesn’t exist. We’re being asked to believe that minor children possess the maturity to make life-altering medical decisions and can fully comprehend the risks of these procedures—those that include everything from incontinence to tissue death to lack of fertility, and worse.
Nothing could be further from the truth.
The increase in a new cohort of the population—de-transitioners—is proof positive of the regretfully life-altering and experimental nature of these kind of “gender affirming” medical interventions. It also demonstrates that children, as easily influenced as they are, must not be used as pawns in a political play that caters to a small but vocal and well-funded minority.
This legislation isn’t hateful or bigoted. It’s a common-sense bill that protects minors when the integrity of their bodies and mental health are on the line. It’s also representative of the widespread and bipartisan support for these kinds of bans, as the majority of Americans oppose “gender affirming care” for minors.
But the tide is turning. Several European countries that once uncritically embraced “gender-affirming care” for minors have already reconsidered or reversed course as the lack of evidence supporting the safety of these procedures and increasing evidence of long-term complications surfaces. The FDA is being sued for allegedly concealing records regarding the off-label use of puberty blockers and cross-sex hormones on minors. Medical malpractice claims against hospital systems that rushed minor children into “gender affirming” surgeries with little to no investigation of the minor’s underlying mental health co-morbidities are on the rise.
Nearly two dozen states have already enacted laws prohibiting “gender-affirming” interventions for minors in most circumstances. Now is the time for South Carolina to join them.
This piece originally appeared in MSN
Yesterday, AAPS (Association of American Physicians and Surgeons) emailed this update:
Building on two recent victories — one in Ohio to protect children from irreversible harm, after we filed a strong amicus brief against transgender procedures on minors, and the second in U.S. Court of Appeals for the 11th Circuit (read our amicus) preventing taxpayer funds from being spent on transgender surgery — AAPS is proud to join a coalition led by the American College of Pediatricians asking the Supreme court of the United States to uphold a Tennessee law blocking transgender operations, and use of related drugs, for children.
Link to Amicus in U.S. vs. Skrmetti: https://aapsonline.org/judicial/amicus-skrmetti-10-18-2024.pdf
Meanwhile, NBC News lays out the legal battleground in Texas.
Texas AG sues doctor accused of providing transgender care to 21 minors
The suit is the first by an attorney general against an individual doctor for allegedly violating a restriction on gender-affirming care for minors. By Matt Lavietes and Jo Yurcaba | Oct. 17, 2024Texas Attorney General Ken Paxton sued a Dallas doctor Thursday accusing her of providing transition-related care to nearly two dozen minors in violation of state law.
Paxton alleged that Dr. May Chi Lau, who specializes in adolescent medicine, provided hormone replacement therapy to 21 minors from October 2023 to August for the purpose of transitioning genders. Texas enacted a law, Senate Bill 14, last year banning hormone replacement therapy and other forms of gender-affirming care for minors.
“Texas passed a law to protect children from these dangerous unscientific medical interventions that have irreversible and damaging effects,” Paxton said in a statement Thursday. “Doctors who continue to provide these harmful ‘gender transition’ drugs and treatments will be prosecuted to the full extent of the law.”
The statement alleged that Lau used "false diagnoses and billing codes" to mask "unlawful prescriptions."
Neither Lau nor her employer, the University of Texas Southwestern Medical Center, immediately replied to requests for comment.
If Lau is found to be in violation of the law, her medical license could be revoked and she could face a financial penalty of hundreds of thousands of dollars.
Paxton’s suit is the first in the country by an attorney general against an individual doctor alleging violation of a restriction on transition-related care for minors.
Texas’ law includes a provision that allows physicians to continue to prescribe puberty blockers and hormone therapy to patients who began treatment before June 1, 2023, in order to wean them off the medications “over a period of time and in a manner that is safe and medically appropriate and that minimizes the risk of complications,” according to Paxton’s suit. Minors are required to have attended at least 12 mental health counseling or psychotherapy sessions for at least six months before they started treatment. It’s unclear whether Lau’s treatment of the minors could fall under that provision.
So far, a few attorneys general, including Paxton, have subpoenaed hospitals and practices that provide such care to minors for those patients’ records. Twenty-six states ban at least some forms of gender-affirming care for minors, according to the Movement Advancement Project, an LGBTQ think tank.
Gov. Greg Abbott signed Texas’ restriction in June 2023, and a court blocked it after families and doctors sued. In September 2023, the Texas Supreme Court allowed the law to take effect pending an appeal from the state, and this June, it vacated and reversed the previous injunction, allowing the law to stand.
The U.S. Supreme Court is expected in its current session to hear oral arguments and rule on whether to strike down a similar law in Tennessee. How the court rules on the Tennessee law is expected to affect similar laws in other states.
The statement from Paxton’s office described gender-affirming care as “experimental, and no scientific evidence supports their supposed benefits.”
Major medical organizations, such as the American Medical Association and the American Academy of Pediatrics, disagree, arguing that transition-related care is an effective and medically necessary way to treat gender dysphoria, which is distress felt by people whose gender identities differ from their genders assigned at birth.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.






















